The Challenge
Despite the global tidal wave of medical cannabis usage, robust clinical data is lacking, and therefore:
- Medical cannabis patients are overwhelmed by product choices and frustrated by high costs and minimal medical guidance
- Growers and producers don’t differentiate their products successfully
- The education and practice of medical cannabis for the conventional medical community is lagging
- Traditional clinical research paradigms are not efficiently capturing real-world data
- The real potential of personalized cannabinoid medicine is not yet being realized
The Solution
Platient Research Technologies is creating an ecosystem for on-demand clinical research with medical cannabis, using real-world decentralized data collection technologies and digital medicine tools.
Our unique approach allows researchers, health-care providers, patients, and technology companies to participate in generation of efficient and robust data.
Our Mission
To improve medical cannabis patient outcomes through innovative, agile, and large-scale research.
We know this will take time. Help us get one step closer.
Contact Us
Platient Research Technologies is developing the first on-demand platform for decentralized clinical research with medical cannabis.
We are seeking collaborations with interested stakeholders, including medical cannabis consumers, health care providers, researchers, product hunters, and technology partners. If you’d like to be part of the change, get updates, or ask any questions – leave your contact information here >>
Cheryl Fitzer-Attas, PhD, MBA Founder and CEO
Cheryl is a PhD/MBA pharmaceutical executive with >20 years of experience in the industry, including key global & US roles in Medical Affairs, Drug Development, and Clinical R&D leadership at start-up, large pharma, and not-for-profit organizations. In the last decade, Cheryl expanded her focus to digital health programs such as the use of wearables in clinical research, pre-competitive consortium for development of digital tools and endpoints, authorship of key industry guidance manuscripts, and the deployment of artificial intelligence in healthcare. At ClinMed, she provides services related to clinical and medical affairs, communications, and business development.
Cheryl is a frustrated medical cannabis patient and a persistent researcher. After initially learning the landscape with cannabis, Cheryl pledged to bring her skill set to the industry, for example as section editor of the Journal of Cannabis Research. This commitment also led her to found Platient Research Technologies, a company developing an on-demand digital platform for clinical research with medical cannabis. Platient aims to close knowledge gaps while overcoming research hurdles and leveraging market realities. Platient’s real-world studies and digital protocols reflect the uniqueness of cannabis as a medicine. Cheryl is working with trusted advisors, collaborators, and partners to turn this ambitious project into a reality.